Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 202 entries
Sorted by: Best Match Show Resources per page
Pregnancy-associated plasma protein-A predicts survival in end-stage renal disease-confounding and modifying effects of cardiovascular disease, body composition and inflammation.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Nilsson E, Cao Y, Lindholm B, Ohyama A, Carrero JJ, Qureshi AR, Stenvinkel P.
PMID: 28967965
Nephrol Dial Transplant. 2017 Oct 01;32(10):1776. doi: 10.1093/ndt/gfx266.

No abstract available.

Cite
Nilsson E, Cao Y, Lindholm B, et al. Pregnancy-associated plasma protein-A predicts survival in end-stage renal disease-confounding and modifying effects of cardiovascular disease, body composition and inflammation. Nephrol Dial Transplant. 2017;32(10):1776doi: 10.1093/ndt/gfx266.
Nilsson, E., Cao, Y., Lindholm, B., Ohyama, A., Carrero, J. J., Qureshi, A. R., & Stenvinkel, P. (2017). Pregnancy-associated plasma protein-A predicts survival in end-stage renal disease-confounding and modifying effects of cardiovascular disease, body composition and inflammation. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 32(10), 1776. https://doi.org/10.1093/ndt/gfx266
Nilsson, Erik, et al. "Pregnancy-associated plasma protein-A predicts survival in end-stage renal disease-confounding and modifying effects of cardiovascular disease, body composition and inflammation." Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association vol. 32,10 (2017): 1776. doi: https://doi.org/10.1093/ndt/gfx266
Nilsson E, Cao Y, Lindholm B, Ohyama A, Carrero JJ, Qureshi AR, Stenvinkel P. Pregnancy-associated plasma protein-A predicts survival in end-stage renal disease-confounding and modifying effects of cardiovascular disease, body composition and inflammation. Nephrol Dial Transplant. 2017 Oct 01;32(10):1776. doi: 10.1093/ndt/gfx266. PMID: 28967965.
Copy Download .nbib Format: NLM
Glucagon-like peptide-1 receptor agonists and the risk of cardiovascular events in diabetes patients surviving an acute myocardial infarction.

European heart journal. Cardiovascular pharmacotherapy

Trevisan M, Fu EL, Szummer K, Norhammar A, Lundman P, Wanner C, Sjölander A, Jernberg T, Carrero JJ.
PMID: 31999317
Eur Heart J Cardiovasc Pharmacother. 2021 Mar 15;7(2):104-111. doi: 10.1093/ehjcvp/pvaa004.

AIMS: Trial evidence indicates that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may reduce the risk of cardiovascular (CV) events in patients with diabetes and myocardial infarction (MI). We aimed to expand this observation to routine care settings.METHODS AND RESULTS:...

Cite
Trevisan M, Fu EL, Szummer K, et al. Glucagon-like peptide-1 receptor agonists and the risk of cardiovascular events in diabetes patients surviving an acute myocardial infarction. Eur Heart J Cardiovasc Pharmacother. 2021;7(2):104-111doi: 10.1093/ehjcvp/pvaa004.
Trevisan, M., Fu, E. L., Szummer, K., Norhammar, A., Lundman, P., Wanner, C., Sjölander, A., Jernberg, T., & Carrero, J. J. (2021). Glucagon-like peptide-1 receptor agonists and the risk of cardiovascular events in diabetes patients surviving an acute myocardial infarction. European heart journal. Cardiovascular pharmacotherapy, 7(2), 104-111. https://doi.org/10.1093/ehjcvp/pvaa004
Trevisan, Marco, et al. "Glucagon-like peptide-1 receptor agonists and the risk of cardiovascular events in diabetes patients surviving an acute myocardial infarction." European heart journal. Cardiovascular pharmacotherapy vol. 7,2 (2021): 104-111. doi: https://doi.org/10.1093/ehjcvp/pvaa004
Trevisan M, Fu EL, Szummer K, Norhammar A, Lundman P, Wanner C, Sjölander A, Jernberg T, Carrero JJ. Glucagon-like peptide-1 receptor agonists and the risk of cardiovascular events in diabetes patients surviving an acute myocardial infarction. Eur Heart J Cardiovasc Pharmacother. 2021 Mar 15;7(2):104-111. doi: 10.1093/ehjcvp/pvaa004. PMID: 31999317; PMCID: PMC7957901.
Copy Download .nbib Format: NLM
Limited capacity of tree growth to mitigate the global greenhouse effect under predicted warming.

Nature communications

Büntgen U, Krusic PJ, Piermattei A, Coomes DA, Esper J, Myglan VS, Kirdyanov AV, Camarero JJ, Crivellaro A, Körner C.
PMID: 31092831
Nat Commun. 2019 May 15;10(1):2171. doi: 10.1038/s41467-019-10174-4.

It is generally accepted that animal heartbeat and lifespan are often inversely correlated, however, the relationship between productivity and longevity has not yet been described for trees growing under industrial and pre-industrial climates. Using 1768 annually resolved and absolutely...

Cite
Büntgen U, Krusic PJ, Piermattei A, et al. Limited capacity of tree growth to mitigate the global greenhouse effect under predicted warming. Nat Commun. 2019;10(1):2171doi: 10.1038/s41467-019-10174-4.
Büntgen, U., Krusic, P. J., Piermattei, A., Coomes, D. A., Esper, J., Myglan, V. S., Kirdyanov, A. V., Camarero, J. J., Crivellaro, A., & Körner, C. (2019). Limited capacity of tree growth to mitigate the global greenhouse effect under predicted warming. Nature communications, 10(1), 2171. https://doi.org/10.1038/s41467-019-10174-4
Büntgen, Ulf, et al. "Limited capacity of tree growth to mitigate the global greenhouse effect under predicted warming." Nature communications vol. 10,1 (2019): 2171. doi: https://doi.org/10.1038/s41467-019-10174-4
Büntgen U, Krusic PJ, Piermattei A, Coomes DA, Esper J, Myglan VS, Kirdyanov AV, Camarero JJ, Crivellaro A, Körner C. Limited capacity of tree growth to mitigate the global greenhouse effect under predicted warming. Nat Commun. 2019 May 15;10(1):2171. doi: 10.1038/s41467-019-10174-4. PMID: 31092831; PMCID: PMC6520339.
Copy Download .nbib Format: NLM
The Stockholm CREAtinine Measurements (SCREAM) project: protocol overview and regional representativeness.

Clinical kidney journal

Runesson B, Gasparini A, Qureshi AR, Norin O, Evans M, Barany P, Wettermark B, Elinder CG, Carrero JJ.
PMID: 26798472
Clin Kidney J. 2016 Feb;9(1):119-27. doi: 10.1093/ckj/sfv117. Epub 2015 Nov 14.

BACKGROUND: We here describe the construction of the Stockholm CREAtinine Measurement (SCREAM) cohort and assess its coverage/representativeness of the Stockholm county in Sweden. SCREAM has the principal aims to estimate the burden and consequences of chronic kidney disease (CKD)...

Cite
Runesson B, Gasparini A, Qureshi AR, et al. The Stockholm CREAtinine Measurements (SCREAM) project: protocol overview and regional representativeness. Clin Kidney J. 2015;9(1):119-27doi: 10.1093/ckj/sfv117.
Runesson, B., Gasparini, A., Qureshi, A. R., Norin, O., Evans, M., Barany, P., Wettermark, B., Elinder, C. G., & Carrero, J. J. (2016). The Stockholm CREAtinine Measurements (SCREAM) project: protocol overview and regional representativeness. Clinical kidney journal, 9(1), 119-27. https://doi.org/10.1093/ckj/sfv117
Runesson, Björn, et al. "The Stockholm CREAtinine Measurements (SCREAM) project: protocol overview and regional representativeness." Clinical kidney journal vol. 9,1 (2016): 119-27. doi: https://doi.org/10.1093/ckj/sfv117
Runesson B, Gasparini A, Qureshi AR, Norin O, Evans M, Barany P, Wettermark B, Elinder CG, Carrero JJ. The Stockholm CREAtinine Measurements (SCREAM) project: protocol overview and regional representativeness. Clin Kidney J. 2016 Feb;9(1):119-27. doi: 10.1093/ckj/sfv117. Epub 2015 Nov 14. PMID: 26798472; PMCID: PMC4720196.
Copy Download .nbib Format: NLM
A cohort study of insulin-like growth factor 1 and mortality in haemodialysis patients.

Clinical kidney journal

Nilsson E, Carrero JJ, Heimbürger O, Hellberg O, Lindholm B, Stenvinkel P.
PMID: 26798476
Clin Kidney J. 2016 Feb;9(1):148-52. doi: 10.1093/ckj/sfv118. Epub 2015 Nov 26.

BACKGROUND: Protein-energy wasting (PEW) is highly prevalent in haemodialysis (HD) patients and associated with increased mortality and cardiovascular disease (CVD). Insulin-like growth factor 1 (IGF-1) correlates to markers of PEW and CVD. Disturbances in the growth hormone axis in...

Cite
Nilsson E, Carrero JJ, Heimbürger O, et al. A cohort study of insulin-like growth factor 1 and mortality in haemodialysis patients. Clin Kidney J. 2015;9(1):148-52doi: 10.1093/ckj/sfv118.
Nilsson, E., Carrero, J. J., Heimbürger, O., Hellberg, O., Lindholm, B., & Stenvinkel, P. (2016). A cohort study of insulin-like growth factor 1 and mortality in haemodialysis patients. Clinical kidney journal, 9(1), 148-52. https://doi.org/10.1093/ckj/sfv118
Nilsson, Erik, et al. "A cohort study of insulin-like growth factor 1 and mortality in haemodialysis patients." Clinical kidney journal vol. 9,1 (2016): 148-52. doi: https://doi.org/10.1093/ckj/sfv118
Nilsson E, Carrero JJ, Heimbürger O, Hellberg O, Lindholm B, Stenvinkel P. A cohort study of insulin-like growth factor 1 and mortality in haemodialysis patients. Clin Kidney J. 2016 Feb;9(1):148-52. doi: 10.1093/ckj/sfv118. Epub 2015 Nov 26. PMID: 26798476; PMCID: PMC4720197.
Copy Download .nbib Format: NLM
Antibiotic Prescribing in New York State Medicare Part B Beneficiaries Diagnosed With Cystitis Between 2016 and 2017.

Open forum infectious diseases

Yu JY, McKenna VA, Dumyati GK, Lubowski TJ, Carreno JJ.
PMID: 31988975
Open Forum Infect Dis. 2020 Jan 04;7(1):ofz544. doi: 10.1093/ofid/ofz544. eCollection 2020 Jan.

BACKGROUND: Statewide tracking and reporting is an outpatient antimicrobial stewardship tool that may be useful for many stakeholders. However, to date, these evaluations have been limited. This study aimed to track and report outpatient antibiotic prescribing in Medicare Part...

Cite
Yu JY, McKenna VA, Dumyati GK, et al. Antibiotic Prescribing in New York State Medicare Part B Beneficiaries Diagnosed With Cystitis Between 2016 and 2017. Open Forum Infect Dis. 2020;7(1):ofz544doi: 10.1093/ofid/ofz544.
Yu, J. Y., McKenna, V. A., Dumyati, G. K., Lubowski, T. J., & Carreno, J. J. (2020). Antibiotic Prescribing in New York State Medicare Part B Beneficiaries Diagnosed With Cystitis Between 2016 and 2017. Open forum infectious diseases, 7(1), ofz544. https://doi.org/10.1093/ofid/ofz544
Yu, Joyce Y, et al. "Antibiotic Prescribing in New York State Medicare Part B Beneficiaries Diagnosed With Cystitis Between 2016 and 2017." Open forum infectious diseases vol. 7,1 (2020): ofz544. doi: https://doi.org/10.1093/ofid/ofz544
Yu JY, McKenna VA, Dumyati GK, Lubowski TJ, Carreno JJ. Antibiotic Prescribing in New York State Medicare Part B Beneficiaries Diagnosed With Cystitis Between 2016 and 2017. Open Forum Infect Dis. 2020 Jan 04;7(1):ofz544. doi: 10.1093/ofid/ofz544. eCollection 2020 Jan. PMID: 31988975; PMCID: PMC6975250.
Copy Download .nbib Format: NLM
Stopping mineralocorticoid receptor antagonists after hyperkalaemia: trial emulation in data from routine care.

European journal of heart failure

Trevisan M, Fu EL, Xu Y, Savarese G, Dekker FW, Lund LH, Clase CM, Sjölander A, Carrero JJ.
PMID: 34196082
Eur J Heart Fail. 2021 Oct;23(10):1698-1707. doi: 10.1002/ejhf.2287. Epub 2021 Jul 18.

AIMS: Whether to continue or stop mineralocorticoid receptor antagonists (MRA) after an episode of hyperkalaemia is a challenge in clinical practice. While stopping MRA may prevent recurrent hyperkalaemias, it deprives patients of their cardioprotection. We here assessed the association...

Cite
Trevisan M, Fu EL, Xu Y, et al. Stopping mineralocorticoid receptor antagonists after hyperkalaemia: trial emulation in data from routine care. Eur J Heart Fail. 2021;23(10):1698-1707doi: 10.1002/ejhf.2287.
Trevisan, M., Fu, E. L., Xu, Y., Savarese, G., Dekker, F. W., Lund, L. H., Clase, C. M., Sjölander, A., & Carrero, J. J. (2021). Stopping mineralocorticoid receptor antagonists after hyperkalaemia: trial emulation in data from routine care. European journal of heart failure, 23(10), 1698-1707. https://doi.org/10.1002/ejhf.2287
Trevisan, Marco, et al. "Stopping mineralocorticoid receptor antagonists after hyperkalaemia: trial emulation in data from routine care." European journal of heart failure vol. 23,10 (2021): 1698-1707. doi: https://doi.org/10.1002/ejhf.2287
Trevisan M, Fu EL, Xu Y, Savarese G, Dekker FW, Lund LH, Clase CM, Sjölander A, Carrero JJ. Stopping mineralocorticoid receptor antagonists after hyperkalaemia: trial emulation in data from routine care. Eur J Heart Fail. 2021 Oct;23(10):1698-1707. doi: 10.1002/ejhf.2287. Epub 2021 Jul 18. PMID: 34196082.
Copy Download .nbib Format: NLM
A Comparative Analysis of Nutritional Assessment Using Global Leadership Initiative on Malnutrition Versus Subjective Global Assessment and Malnutrition Inflammation Score in Maintenance Hemodialysis Patients.

Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation

Avesani CM, Sabatino A, Guerra A, Rodrigues J, Carrero JJ, Rossi GM, Garibotto G, Stenvinkel P, Fiaccadori E, Lindholm B.
PMID: 34330567
J Ren Nutr. 2021 Jul 27; doi: 10.1053/j.jrn.2021.06.008. Epub 2021 Jul 27.

OBJECTIVE: Malnutrition is a prevalent condition in maintenance hemodialysis (MHD) patients. This study aimed to evaluate the performance of the recently developed GLIM (Global Leadership Initiative on Malnutrition) in MHD by assessing the agreement, accuracy, sensitivity, specificity, and survival...

Cite
Avesani CM, Sabatino A, Guerra A, et al. A Comparative Analysis of Nutritional Assessment Using Global Leadership Initiative on Malnutrition Versus Subjective Global Assessment and Malnutrition Inflammation Score in Maintenance Hemodialysis Patients. J Ren Nutr. 2021;doi: 10.1053/j.jrn.2021.06.008.
Avesani, C. M., Sabatino, A., Guerra, A., Rodrigues, J., Carrero, J. J., Rossi, G. M., Garibotto, G., Stenvinkel, P., Fiaccadori, E., & Lindholm, B. (2021). A Comparative Analysis of Nutritional Assessment Using Global Leadership Initiative on Malnutrition Versus Subjective Global Assessment and Malnutrition Inflammation Score in Maintenance Hemodialysis Patients. Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation, . https://doi.org/10.1053/j.jrn.2021.06.008
Avesani, Carla Maria, et al. "A Comparative Analysis of Nutritional Assessment Using Global Leadership Initiative on Malnutrition Versus Subjective Global Assessment and Malnutrition Inflammation Score in Maintenance Hemodialysis Patients." Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation vol. (2021). doi: https://doi.org/10.1053/j.jrn.2021.06.008
Avesani CM, Sabatino A, Guerra A, Rodrigues J, Carrero JJ, Rossi GM, Garibotto G, Stenvinkel P, Fiaccadori E, Lindholm B. A Comparative Analysis of Nutritional Assessment Using Global Leadership Initiative on Malnutrition Versus Subjective Global Assessment and Malnutrition Inflammation Score in Maintenance Hemodialysis Patients. J Ren Nutr. 2021 Jul 27; doi: 10.1053/j.jrn.2021.06.008. Epub 2021 Jul 27. PMID: 34330567.
Copy Download .nbib Format: NLM
Computed structures of core eukaryotic protein complexes.

Science (New York, N.Y.)

Humphreys IR, Pei J, Baek M, Krishnakumar A, Anishchenko I, Ovchinnikov S, Zhang J, Ness TJ, Banjade S, Bagde SR, Stancheva VG, Li XH, Liu K, Zheng Z, Barrero DJ, Roy U, Kuper J, Fernández IS, Szakal B, Branzei D, Rizo J, Kisker C, Greene EC, Biggins S, Keeney S, Miller EA, Fromme JC, Hendrickson TL, Cong Q, Baker D.
PMID: 34762488
Science. 2021 Dec 10;374(6573):eabm4805. doi: 10.1126/science.abm4805. Epub 2021 Dec 10.

[Figure: see text].

Cite
Humphreys IR, Pei J, Baek M, et al. Computed structures of core eukaryotic protein complexes. Science. 2021;374(6573):eabm4805doi: 10.1126/science.abm4805.
Humphreys, I. R., Pei, J., Baek, M., Krishnakumar, A., Anishchenko, I., Ovchinnikov, S., Zhang, J., Ness, T. J., Banjade, S., Bagde, S. R., Stancheva, V. G., Li, X. H., Liu, K., Zheng, Z., Barrero, D. J., Roy, U., Kuper, J., Fernández, I. S., Szakal, B., Branzei, D., Rizo, J., Kisker, C., Greene, E. C., Biggins, S., Keeney, S., Miller, E. A., Fromme, J. C., Hendrickson, T. L., Cong, Q., & Baker, D. (2021). Computed structures of core eukaryotic protein complexes. Science (New York, N.Y.), 374(6573), eabm4805. https://doi.org/10.1126/science.abm4805
Humphreys, Ian R, et al. "Computed structures of core eukaryotic protein complexes." Science (New York, N.Y.) vol. 374,6573 (2021): eabm4805. doi: https://doi.org/10.1126/science.abm4805
Humphreys IR, Pei J, Baek M, Krishnakumar A, Anishchenko I, Ovchinnikov S, Zhang J, Ness TJ, Banjade S, Bagde SR, Stancheva VG, Li XH, Liu K, Zheng Z, Barrero DJ, Roy U, Kuper J, Fernández IS, Szakal B, Branzei D, Rizo J, Kisker C, Greene EC, Biggins S, Keeney S, Miller EA, Fromme JC, Hendrickson TL, Cong Q, Baker D. Computed structures of core eukaryotic protein complexes. Science. 2021 Dec 10;374(6573):eabm4805. doi: 10.1126/science.abm4805. Epub 2021 Dec 10. PMID: 34762488.
Copy Download .nbib Format: NLM
Declines in canopy greenness and tree growth are caused by combined climate extremes during drought-induced dieback.

The Science of the total environment

Castellaneta M, Rita A, Camarero JJ, Colangelo M, Ripullone F.
PMID: 34968613
Sci Total Environ. 2021 Dec 27;813:152666. doi: 10.1016/j.scitotenv.2021.152666. Epub 2021 Dec 27.

Several dieback episodes triggered by droughts are revealing the high vulnerability of Mediterranean forests, manifested as declines in growth, increased defoliation, and rising mortality rates. Understanding forest responses to such climate extreme events is of high priority for predicting...

Cite
Castellaneta M, Rita A, Camarero JJ, et al. Declines in canopy greenness and tree growth are caused by combined climate extremes during drought-induced dieback. Sci Total Environ. 2021;813:152666doi: 10.1016/j.scitotenv.2021.152666.
Castellaneta, M., Rita, A., Camarero, J. J., Colangelo, M., & Ripullone, F. (2021). Declines in canopy greenness and tree growth are caused by combined climate extremes during drought-induced dieback. The Science of the total environment, 813152666. https://doi.org/10.1016/j.scitotenv.2021.152666
Castellaneta, Maria, et al. "Declines in canopy greenness and tree growth are caused by combined climate extremes during drought-induced dieback." The Science of the total environment vol. 813 (2021): 152666. doi: https://doi.org/10.1016/j.scitotenv.2021.152666
Castellaneta M, Rita A, Camarero JJ, Colangelo M, Ripullone F. Declines in canopy greenness and tree growth are caused by combined climate extremes during drought-induced dieback. Sci Total Environ. 2021 Dec 27;813:152666. doi: 10.1016/j.scitotenv.2021.152666. Epub 2021 Dec 27. PMID: 34968613.
Copy Download .nbib Format: NLM
Net Endogenous Acid Excretion and Kidney Allograft Outcomes.

Clinical journal of the American Society of Nephrology : CJASN

Yeung SMH, Gomes-Neto AW, Osté MCJ, van den Berg E, Kootstra-Ros JE, Sanders JSF, Berger SP, Carrero JJ, De Borst MH, Navis GJ, Bakker SJL.
PMID: 34135022
Clin J Am Soc Nephrol. 2021 Sep;16(9):1398-1406. doi: 10.2215/CJN.00780121. Epub 2021 Jun 16.

BACKGROUND AND OBJECTIVES: High dietary acid load may accelerate a decline in kidney function. We prospectively investigated whether dietary acid load is associated with graft outcomes in kidney transplant recipients, and whether venous bicarbonate mediates this association.DESIGN, SETTING, PARTICIPANTS,...

Cite
Yeung SMH, Gomes-Neto AW, Osté MCJ, et al. Net Endogenous Acid Excretion and Kidney Allograft Outcomes. Clin J Am Soc Nephrol. 2021;16(9):1398-1406doi: 10.2215/CJN.00780121.
Yeung, S. M. H., Gomes-Neto, A. W., Osté, M. C. J., van den Berg, E., Kootstra-Ros, J. E., Sanders, J. S. F., Berger, S. P., Carrero, J. J., De Borst, M. H., Navis, G. J., & Bakker, S. J. L. (2021). Net Endogenous Acid Excretion and Kidney Allograft Outcomes. Clinical journal of the American Society of Nephrology : CJASN, 16(9), 1398-1406. https://doi.org/10.2215/CJN.00780121
Yeung, Stanley M H, et al. "Net Endogenous Acid Excretion and Kidney Allograft Outcomes." Clinical journal of the American Society of Nephrology : CJASN vol. 16,9 (2021): 1398-1406. doi: https://doi.org/10.2215/CJN.00780121
Yeung SMH, Gomes-Neto AW, Osté MCJ, van den Berg E, Kootstra-Ros JE, Sanders JSF, Berger SP, Carrero JJ, De Borst MH, Navis GJ, Bakker SJL. Net Endogenous Acid Excretion and Kidney Allograft Outcomes. Clin J Am Soc Nephrol. 2021 Sep;16(9):1398-1406. doi: 10.2215/CJN.00780121. Epub 2021 Jun 16. PMID: 34135022; PMCID: PMC8729579.
Copy Download .nbib Format: NLM
The Stockholm CREAtinine Measurements (SCREAM) project: Fostering improvements in chronic kidney disease care.

Journal of internal medicine

Carrero JJ, Elinder CG.
PMID: 35028991
J Intern Med. 2022 Jan 13; doi: 10.1111/joim.13418. Epub 2022 Jan 13.

SCREAM (Stockholm CREAtinine Measurements project) was initiated in 2010 in collaboration with the healthcare provider of Stockholm County healthcare to quantify potential medication errors, estimate the burden of chronic kidney disease (CKD) and to illustrate the value of incorporating...

Cite
Carrero JJ, Elinder CG. The Stockholm CREAtinine Measurements (SCREAM) project: Fostering improvements in chronic kidney disease care. J Intern Med. 2022;doi: 10.1111/joim.13418.
Carrero, J. J., & Elinder, C. G. (2022). The Stockholm CREAtinine Measurements (SCREAM) project: Fostering improvements in chronic kidney disease care. Journal of internal medicine, . https://doi.org/10.1111/joim.13418
Carrero, Juan Jesus, and Elinder, Carl Gustaf. "The Stockholm CREAtinine Measurements (SCREAM) project: Fostering improvements in chronic kidney disease care." Journal of internal medicine vol. (2022). doi: https://doi.org/10.1111/joim.13418
Carrero JJ, Elinder CG. The Stockholm CREAtinine Measurements (SCREAM) project: Fostering improvements in chronic kidney disease care. J Intern Med. 2022 Jan 13; doi: 10.1111/joim.13418. Epub 2022 Jan 13. PMID: 35028991.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 202 entries